Use of citrate formulas in patients with gout and nephrolithiasis

Use of citrate formulas in patients with gout and nephrolithiasis

Saved in:

Bibliographic Details
Main Authors:	F M Kudaeva, M S Eliseev, V G Barskova, F M Kudayeva, M S Yeliseyev
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2007-09-01
Series:	Современная ревматология
Online Access:	https://mrj.ima-press.net/mrj/article/view/129
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Use of Blemaren citrate formula in gout patients with nephrolithiasis
by: M S Eliseev, et al.
Published: (2008-09-01)

Experience with Uralyt-U citralite used in patients with gout and nephrolithiasis
by: Maksim Sergeyevich Eliseyev, et al.
Published: (2012-09-01)

Clinical experience with Uralyt-U used in patients with gout and nephrolithiasis
by: M S Eliseyev, et al.
Published: (2012-03-01)

Glomerular filtration rate in patients with gout and factors influencing the rate
by: F M Kudaeva, et al.
Published: (2007-09-01)

Impact of age on the frequency and magnitude of the signs of metabolic syndrome in patients with gout
by: V A Nasonova, et al.
Published: (2007-09-01)

GOUT OUTCOMES. LITERATURE REVIEW. PART II. COMORBID DISEASES, RISK OF DEVELOPING CARDIOVASCULAR CATASTROPHES AND DEATH IN GOUT PATIENTS
by: Igor Sergeevich Denisov, et al.
Published: (2014-02-01)

Rational approaches to treating gout
by: V G Barskova, et al.
Published: (2008-03-01)

Use of etoricoxib in patients with gout in real clinical practice
by: M S Eliseyev, et al.
Published: (2013-06-01)

Rational approaches to diagnosing gout (according to the European Antirheumatic League Guidelines)
by: V G Barskova, et al.
Published: (2007-09-01)

Etoricoxib (arcoxia) in rheumatology
by: Fatima Magomedovna Kudaeva, et al.
Published: (2011-06-01)

SIGNIFICANCE OF DIET AND DIETARY SUPPLEMENTS IN GOUT
by: A E Il'ina, et al.
Published: (2008-12-01)

Artropatiya Sharko: mesto vstrechi revmatologa i endokrinologa
by: F M Kudaeva, et al.
Published: (2010-12-01)

Prevalence and risk f actors influencing the development of arterial hypertension in patients with a gout
by: E. I. Markelova, et al.
Published: (2021-01-01)

EXPERIENCE OF ADMINISTRATION OF CANAKINUMAB, AN INTERLEUKIN 1β INHIBITOR, IN A PATIENT WITH CHRONIC TOPHACACEOUS GOUT
by: Maksim Sergeyevna Eliseev, et al.
Published: (2014-03-01)

How to optimize treatment in patients with gout and chronic arthritis Urisan is in focus
by: A E Ilyina, et al.
Published: (2009-03-01)

Nefrolitiaz u bol'nykh podagroy i pokazaniya k naznacheniyu tsitratnykh smesey
by: F M Kudaeva, et al.
Published: (2008-04-01)

Experience in treating a gout patient with adrenal insufficiency
by: Viktoria Georgiyevna Barskova, et al.
Published: (2012-12-01)

OSTEOPOROSIS IN CALCIUM PYROPHOSPHATE CRYSTAL DEPOSITION DISEASE
by: S A Vladimirov, et al.
Published: (2013-02-01)

Type 2 diabetes mellitus and gout
by: O. V. Zhelyabina, et al.
Published: (2021-10-01)

MORPHOLOGICAL CHANGES OF RENAL STAGHORN NEPHROLITHIASIS.
by: M. I. Kogan, et al.
Published: (2015-03-01)

Therapy for psoriatic arthritis with infliximab
by: V V Badokin, et al.
Published: (2009-03-01)

NEW INTERNATIONAL RECOMMENDATIONS FOR THE DIAGNOSIS AND TREATMENT OF GOUT
by: M. S. Eliseev
Published: (2014-06-01)

Febuxostat in patients with hyperuricemia and gout: is the nephroprotective effect real?
by: M. S. Eliseev, et al.
Published: (2024-10-01)

UPDATED EULAR GUIDELINES FOR THE MANAGEMENT OF GOUT. COMMENTS ON CERTAIN ITEMS
by: M. S. Eliseev
Published: (2018-01-01)

Febuxostat in the therapy of gout: from theory to practice
by: E. V. Ilyinykh, et al.
Published: (2018-01-01)

Prospects for using injectable meloxicam (Amelotex®) in patients with osteoarthrosis
by: M S Eliseyev, et al.
Published: (2009-03-01)

Diet for gout and hyperuricaemia: some important questions
by: O. V. Zhelyabina, et al.
Published: (2024-02-01)

Herbal preparations for cure and preventive care of phosphate nephrolithiasis
by: N. G. Chaban, et al.
Published: (2015-06-01)

The monograph «Behchet's disease» by Z.S. Alekberova
by: V G Barskova, et al.
Published: (2008-03-01)

European League Against Rheumatism recommendations for terminologyand diagnosis of calcium pyrophosphate crystal deposition disease: Expert comment
by: V G Barskova, et al.
Published: (2011-06-01)

Spinal involvement in gout simulating spondyloarthritis (clinical case)
by: Y. I. Kuzmina, et al.
Published: (2024-02-01)

Comments on the updated recommendations of the American College of Rheumatology (ACR) for the treatment of gout. Lifestyle (part 2)
by: M. S. Eliseev
Published: (2021-04-01)

USE OF INJECTABLE MELOXICAM (AMELOTEX®) FORMULATION IN PATIENTS WITH GONARTHROSIS
by: M S Eliseyev, et al.
Published: (2009-09-01)

The prevalence and factors associated with coronary heart disease in patients with gout
by: E. I. Markelova, et al.
Published: (2023-10-01)

COMBINED TREATMENT FOR DENDRITIC NEPHROLITHIASIS. CLINICAL CASE
by: V. L. Medvedev, et al.
Published: (2019-03-01)

Comparison of the efficacy and safety of various anti-inflammatory drugs in urate-lowering therapy initiation in patients with gout (preliminary data)
by: M. N. Chikina, et al.
Published: (2021-04-01)

Commentaries on the updated American College of Rheumatology guidelines for the management of gout. Urate-lowering drugs (Part 1)
by: M. S. Eliseev
Published: (2020-09-01)

ASSESMENT TUBULOINTERSTITIAL CHANGES IN THE RENAL PARENCHYMA IN THE SURGICAL TREATMENT OF NEPHROLITHIASIS
by: G. N. Maslyakova, et al.
Published: (2014-03-01)

The role of vegetarian diet in Nephrolithiasis
by: Karolina Zinkow-Krzemyk
Published: (2024-11-01)

The genetic framework for development of nephrolithiasis
by: Vinaya Vasudevan, et al.
Published: (2017-01-01)